chr7-102761319-C-A

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_001145268.2(FAM185A):​c.701C>A​(p.Thr234Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000291 in 1,546,852 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000059 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000026 ( 0 hom. )

Consequence

FAM185A
NM_001145268.2 missense

Scores

2
12
5

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.63

Publications

0 publications found
Variant links:
Genes affected
FAM185A (HGNC:22412): (family with sequence similarity 185 member A)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.845

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FAM185ANM_001145268.2 linkc.701C>A p.Thr234Asn missense_variant Exon 4 of 8 ENST00000413034.3 NP_001138740.2 Q8N0U4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FAM185AENST00000413034.3 linkc.701C>A p.Thr234Asn missense_variant Exon 4 of 8 5 NM_001145268.2 ENSP00000395340.2 Q8N0U4-1

Frequencies

GnomAD3 genomes
AF:
0.0000592
AC:
9
AN:
152060
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000258
AC:
36
AN:
1394792
Hom.:
0
Cov.:
30
AF XY:
0.0000320
AC XY:
22
AN XY:
687732
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31214
American (AMR)
AF:
0.00
AC:
0
AN:
34962
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25080
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35256
South Asian (SAS)
AF:
0.0000383
AC:
3
AN:
78316
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49458
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5678
European-Non Finnish (NFE)
AF:
0.0000306
AC:
33
AN:
1076900
Other (OTH)
AF:
0.00
AC:
0
AN:
57928
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000592
AC:
9
AN:
152060
Hom.:
0
Cov.:
31
AF XY:
0.0000269
AC XY:
2
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.0000242
AC:
1
AN:
41392
American (AMR)
AF:
0.00
AC:
0
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68018
Other (OTH)
AF:
0.00
AC:
0
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000847
Hom.:
0
Bravo
AF:
0.0000491

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 07, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.701C>A (p.T234N) alteration is located in exon 4 (coding exon 4) of the FAM185A gene. This alteration results from a C to A substitution at nucleotide position 701, causing the threonine (T) at amino acid position 234 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.64
BayesDel_addAF
Uncertain
0.020
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.23
.;T
Eigen
Uncertain
0.61
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.87
D;D
M_CAP
Benign
0.025
D
MetaRNN
Pathogenic
0.84
D;D
MetaSVM
Benign
-0.42
T
MutationAssessor
Uncertain
2.9
.;M
PhyloP100
5.6
PrimateAI
Uncertain
0.59
T
PROVEAN
Uncertain
-4.0
D;D
REVEL
Uncertain
0.36
Sift
Uncertain
0.0040
D;D
Sift4G
Uncertain
0.0080
D;D
Polyphen
1.0
D;D
Vest4
0.66
MutPred
0.72
.;Gain of relative solvent accessibility (P = 0.0479);
MVP
0.21
ClinPred
0.98
D
GERP RS
4.2
Varity_R
0.38
gMVP
0.78
Mutation Taster
=55/45
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs770103710; hg19: chr7-102401766; API